PharmaKinnex

AUGUST 23, 2022

Bearing the brunt of these COVID19 restrictions, pharmaceutical reps have had a hard time getting in the door to make sales, and their employers have noticed: Limited In-Person Access To HCPs. Increased Product & Legal Knowledge Requirements. Fewer Networking & Industry Trade Show Events.

Pharma 52

Pharma Sales Sales Strategy Marketing 52

Contrarian Sales Techniques

APRIL 19, 2022

They are responsible for creating demand for existing pharmaceutical products and bringing new products to the market to ensure availability for suppliers. They will be located in a specific geographical location, but it is likely that they will specialize in certain products or medical therapeutic areas.

Medical sales 52

Medical sales Medical Sales Doctors 52

European Pharmaceutical Review

APRIL 21, 2023

4 Together with a legal expert from the Bucerius Law School Hamburg, we looked at the legal and political frameworks that could enable the German pharmaceutical sector to become more sustainable. 7 We would also argue that the pharmaceutical sector should be identified as a “high-impact” sector, given its significant ecological impact.

Pharma 77

Pharma Food and Drug Administration Medicine Pharmaceutical 77

Contrarian Sales Techniques

APRIL 19, 2022

They are responsible for creating demand for existing pharmaceutical products and bringing new products to the market to ensure availability for suppliers. They will be located in a specific geographical location, but it is likely that they will specialize in certain products or medical areas.

Medical sales 52

Medical sales Medical Sales Doctors 52

European Pharmaceutical Review

JANUARY 16, 2023

Clearly the number one challenge in 2022, as mandated by the EU GMP Guidelines for the Manufacture of Sterile Medicinal Products Annex 1 1 , is the development of a Contamination Control Strategy (CCS),” Tony Cundell noted. He questioned how regulators will enforce revisions to Good Manufacturing Practice (GMP) regulations.

Pharmaceutical 124

Pharmaceutical Food and Drug Administration Manufacturing FDA 124

European Pharmaceutical Review

JULY 25, 2022

To appreciate the scope of the challenge facing the pharmaceutical market, as well as patients across the globe, we must understand that there are two distinct threats – ‘counterfeit’ and ‘falsified’ medicines. There is also the challenge of falsified medicines – the fake, unauthorised medical products that make their way into the market.

Pharmaceutical 79

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 79

Pharmaceutical Technology

JANUARY 16, 2023

Under this act, pharmaceutical companies operating in the US will also have to contend with the imposition of inflationary rebates for Medicare utilization in 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets.

Pharma 64

Pharma Manufacturing Pharmaceutical Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

Under this act, pharmaceutical companies operating in the US will also have to contend with the imposition of inflationary rebates for Medicare utilization in 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets.

Pharma 52

Pharma Manufacturing Pharmaceutical Marketing 52

Pharmaceutical Technology

JANUARY 20, 2023

And delays in the supply chain, even for short periods of time can potentially affect the efficacy of medicines, lead to longer-term supply bottlenecks, and ultimately prevent people from getting access to the critical medicines they need. Pharma manufacturing can also be affected by extreme weather events, such as storms.

Pharma 142

Pharma Manufacturing Pharmaceutical Distribution 142

Pharmaceutical Technology

FEBRUARY 15, 2023

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised. But this results in huge, complex datasets.

Pharma 52

Pharma Pharmaceutical Manufacturing Medicine 52